VC23

Codetta Bio develops innovative multi-omic analysis tools for comprehensive biomarker measurement. Its platform combines digital PCR and qPCR technologies to understand genetic, environmental, lifestyle, and clinical factors contributing to individual health, enabling accurate insights from a single specimen.

Fluent BioSciences is a life science technology company focused on single-cell molecular analysis, eliminating the need for complex microfluidic instrumentation. The company’s proprietary platform, Pre-Templated Instant Partitions (PIPseqTM), facilitates the instantaneous self-assembly of individual cells or molecules into millions of uniform partitions. This innovative approach allows for sensitive and unbiased preparation of proteins and nucleic acids, enhancing sequencing applications. By making single-cell and molecular analysis more accessible, Fluent BioSciences enables a broader range of researchers in biotechnology, pharmaceuticals, and academic institutions to conduct advanced analyses, thereby expanding market opportunities within the life sciences field.

Tangen Biosciences LLC is focused on developing a molecular diagnostics platform that facilitates rapid and accurate detection of specific DNAs and RNAs. Utilizing a rotary rapid isothermal nucleic acid detection technique, the platform operates without the need for laboratory facilities, allowing for direct detection from specimens. This innovation enables healthcare providers to conduct precise and cost-effective DNA nucleic tests, enhancing diagnostic capabilities in various clinical settings. The technology offers the specificity and sensitivity comparable to traditional polymerase chain reaction (PCR) methods, thereby improving the efficiency of nucleic acid detection in medical diagnostics.